ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Florida » Geriatric Medicine

Top Geriatric Medicine Prescribers in Florida

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SEGISMUNDO PARES M.D.

Geriatric Medicine

2,483

$93.8K

120
115 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $54

GOKHAN GUVENLI MD

Geriatric Medicine

2,256

$115K

367
322 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $54

HAROLD KAPLAN MD

Geriatric Medicine

2,229

$136K

119
112 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $54

LAWRENCE DORF M.D.

Geriatric Medicine

1,888

$86.4K

131
123 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $54

EDUARDO DIAZ M.D.

Geriatric Medicine

1,883

$90K

63
59 are 65+

35%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $54

HARRIS MONES D.O

Geriatric Medicine

1,747

$103K

160
118 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $54

ANTHONY ALATRISTE MD

Geriatric Medicine

1,724

$83K

601
342 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $54

HADY MASRI D.O.

Geriatric Medicine

1,589

$81.3K

155
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$51
Average prescription price

Avg: $54

DARSHAN SHAH MD

Geriatric Medicine

1,579

$102K

236
194 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

11%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$65
Average prescription price

Avg: $54

ARIEL COLE M.D.

Geriatric Medicine

1,548

$88.9K

154
130 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $54

MEGUMI MAGUCHI M.D.

Geriatric Medicine

1,446

$71.1K

225
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $54

MINA ZEINI M.D

Geriatric Medicine

1,438

$77.8K

206
122 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $54

JACK GOLOFF D.O.

Geriatric Medicine

1,383

$130K

40
0 are 65+

93%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$94
Average prescription price

Avg: $54

GARY MILLER MD

Geriatric Medicine

1,376

$85.4K

83
66 are 65+

24%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$62
Average prescription price

Avg: $54

ANNA PARE-MONDERSON M.D.

Geriatric Medicine

1,250

$62.8K

161
117 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $54

DAVID KRAMER MD

Geriatric Medicine

949

$43.6K

93
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $54

HIEP NGUYEN MD

Geriatric Medicine

824

$15.6K

57
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$19
Average prescription price

Avg: $54

MICHAEL RAAB MD

Geriatric Medicine

811

$153K

180
178 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 25%

$189
Average prescription price

Avg: $54

ANGELICA JIMENEZ M.D.

Geriatric Medicine

655

$31.1K

80
46 are 65+

25%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 25%

$47
Average prescription price

Avg: $54

JERROLD ECKLIND D.O.

Geriatric Medicine

564

$21.4K

177
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$38
Average prescription price

Avg: $54

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank